Author:
Vai Benedetta,Mazza Mario Gennaro
Subject
Behavioral Neuroscience,Endocrine and Autonomic Systems,Immunology
Reference10 articles.
1. Can cytokine blocking prevent depression in COVID-19 survivors?;Benedetti;J. Neuroimmune Pharmacol.,2021
2. El Abdellati, K., Lucas, A., Perron, H., Tamouza, R., Nkam, I., Richard, J., Fried, S., Barau, C., Djonouma, N., Pinot, A., 2023. High unrecognized SARS-CoV-2 exposure of newly admitted and hospitalized psychiatric patients. Brain, Behavior, and Immunity.
3. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression;Liu;J. Affective Disorders,2012
4. Cytokine prediction of mortality in COVID19 patients;Mandel;Cytokine,2020
5. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment;Mazza;CNS Drugs,2022